Patent details

Basic Information

Publication number:

EP3565571

PCT Application Number:

EP2018050336

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP187024088

PCT Publication Number:

WO2018127582

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ALICAFORSEN FORMULATIONS

French Title of Invention:

FORMULATIONS D'ALICAFORSEN

German Title of Invention:

ALICAFORSEN FORMULIERUNGEN

SPC Number:

Dates

Filing date:

08/01/2018

Grant date:

23/03/2022

EP Publication Date:

13/11/2019

PCT Publication Date:

12/07/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/03/2022

EP B1 Publication Date:

23/03/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/01/2023

Expiration date:

08/01/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/03/2022

 

 

Name:

Atlantic Pharmaceuticals (Holdings) Ltd

Address:

Atlantic House, 12 Rose & Crown Walk, Saffron Walden, Essex CB10 1JH, United Kingdom (GB)

Inventor

1

Name:

WEBB, Michael

Address:

United Kingdom (GB)

2

Name:

THOMAS, Janette

Address:

United Kingdom (GB)

3

Name:

WATERWORTH, Toby

Address:

United Kingdom (GB)

4

Name:

JOHNSON, Lorin

Address:

United Kingdom (GB)

Priority

Priority Number:

201700257

Priority Date:

06/01/2017

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 38/00; C12N 15/113; A61P 29/00;

Publication

European Patent Bulletin

Issue number:

202212

Publication date:

23/03/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages